首页 > 最新文献

Acta Pharmaceutica最新文献

英文 中文
Cloning, expression, and purification of recombinant AKR1D1 for therapeutic applications. 用于治疗的重组AKR1D1的克隆、表达和纯化。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-04-10 Print Date: 2025-03-01 DOI: 10.2478/acph-2025-0003
Kristina Shutevska, Aleksandra Kapedanovska Nestorovska

AKR1D1, a key enzyme in the aldo-keto reductase superfamily, plays a dual role in both steroid metabolism and bile acid synthesis by catalyzing the NADPH-dependent reduction of carbon-carbon double bonds, specifically converting 3-ketosteroid hormones into 5β-steroids. Positioned at the critical intersection of steroid hormone and bile acid metabolism, AKR1D1 has the potential to profoundly influence metabolic homeostasis and drug metabolism. Despite its importance, the enzyme's therapeutic implications and role in drug metabolism remain underexplored. This study presents an optimized methodology for the cloning, expression, and purification of AKR1D1 using an Escherichia coli expression system. We identified optimal conditions for ligation and precise DNA sequencing, emphasizing the need for lower DNA concentrations and higher purity. Protein expression was evaluated in E. coli strains BL21 and Rosetta, with the highest yields achieved under extended incubation at 25 °C with controlled IPTG concentrations. Using freshly transformed cells was essential for maintaining consistent protein expression. The enzyme's activity was confirmed using a spectrofluorometric assay, demonstrating efficient reduction of testosterone to 5β-DHT. This optimized methodology facilitates the production of AKR1D1 with high specific activity, establishing a valuable platform for future research. It enables a deeper investigation into AKR1D1's contributions to drug metabolism and its therapeutic potential.

AKR1D1是醛酮还原酶超家族中的关键酶,通过催化nadph依赖性碳-碳双键的还原,特异性地将3-酮类固醇激素转化为5 - β-类固醇,在类固醇代谢和胆汁酸合成中发挥双重作用。AKR1D1位于类固醇激素和胆汁酸代谢的关键交叉点,具有深刻影响代谢稳态和药物代谢的潜力。尽管它很重要,但这种酶的治疗意义和在药物代谢中的作用仍未得到充分探讨。本研究提出了一种利用大肠杆菌表达系统克隆、表达和纯化AKR1D1的优化方法。我们确定了结扎和精确DNA测序的最佳条件,强调需要更低的DNA浓度和更高的纯度。在大肠杆菌菌株BL21和Rosetta中评估了蛋白表达,在25°C和控制IPTG浓度的延长孵育下获得了最高产量。使用新转化的细胞对于保持一致的蛋白质表达至关重要。该酶的活性用荧光光谱法证实,证明了睾丸激素有效地还原为5β-二氢睾酮。优化后的方法有利于生产高比活性的AKR1D1,为今后的研究奠定了有价值的平台。它使我们能够更深入地研究AKR1D1对药物代谢的贡献及其治疗潜力。
{"title":"Cloning, expression, and purification of recombinant AKR1D1 for therapeutic applications.","authors":"Kristina Shutevska, Aleksandra Kapedanovska Nestorovska","doi":"10.2478/acph-2025-0003","DOIUrl":"10.2478/acph-2025-0003","url":null,"abstract":"<p><p>AKR1D1, a key enzyme in the aldo-keto reductase superfamily, plays a dual role in both steroid metabolism and bile acid synthesis by catalyzing the NADPH-dependent reduction of carbon-carbon double bonds, specifically converting 3-ketosteroid hormones into 5β-steroids. Positioned at the critical intersection of steroid hormone and bile acid metabolism, AKR1D1 has the potential to profoundly influence metabolic homeostasis and drug metabolism. Despite its importance, the enzyme's therapeutic implications and role in drug metabolism remain underexplored. This study presents an optimized methodology for the cloning, expression, and purification of AKR1D1 using an <i>Escherichia coli</i> expression system. We identified optimal conditions for ligation and precise DNA sequencing, emphasizing the need for lower DNA concentrations and higher purity. Protein expression was evaluated in <i>E. coli</i> strains BL21 and Rosetta, with the highest yields achieved under extended incubation at 25 °C with controlled IPTG concentrations. Using freshly transformed cells was essential for maintaining consistent protein expression. The enzyme's activity was confirmed using a spectrofluorometric assay, demonstrating efficient reduction of testosterone to 5β-DHT. This optimized methodology facilitates the production of AKR1D1 with high specific activity, establishing a valuable platform for future research. It enables a deeper investigation into AKR1D1's contributions to drug metabolism and its therapeutic potential.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":" ","pages":"147-157"},"PeriodicalIF":2.1,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142833396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating network pharmacology and in vivo model to reveal the cardiovascular protective effects of kaempferol-3-O-rutinoside on heart failure. 整合网络药理学和体内模型,揭示山奈酚-3-O-芸香糖苷对心衰的心血管保护作用
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-04-10 Print Date: 2025-03-01 DOI: 10.2478/acph-2025-0001
Lu-Qin Guo, Lan Zhou, Sheng-Nan Li, Juan Bai, Ling-Li Shi, Fang Hua, Peng Zhou

Kaempferol-3-O-rutinoside (KR) has an excellent cardioprotective effect, but its mechanism of action is not clear. Network pharmacology was used to predict the signaling pathways, whereas molecular docking was used for preliminary validation of KR binding to targets. AMI model rats with ligated left anterior descending coronary arteries were established. HE staining was used to detect pathological changes, and ELISA was used to detect the expression of TNF-α and IL-6. Network pharmacology results showed PI3K-AKT signaling pathway may be the main mechanism, and molecular docking predicted that KR could bind strongly to the PI3K and AKT. KR could significantly reduce cardiac pathological changes, decrease the level of TNF-α and IL-6, and enhance the mRNA and protein expressions of PI3K and AKT. KR ameliorates HF after AMI by enhancing the expressions of PI3K and AKT, which will be helpful in elucidating the mechanism of KR through multiple techniques.

山奈酚-3- o -芦丁苷(KR)具有良好的心脏保护作用,但其作用机制尚不清楚。网络药理学用于预测信号通路,而分子对接用于初步验证KR与靶点的结合。建立冠脉左前降支结扎大鼠AMI模型。采用HE染色检测病理变化,ELISA检测TNF-α、IL-6的表达。网络药理学结果显示PI3K-AKT信号通路可能是其主要机制,分子对接预测KR能与PI3K和AKT强结合。KR能显著减轻心脏病理改变,降低TNF-α、IL-6水平,提高PI3K、AKT mRNA和蛋白表达。KR通过提高PI3K和AKT的表达来改善AMI后HF,这将有助于通过多种技术阐明KR的作用机制。
{"title":"Integrating network pharmacology and <i>in vivo</i> model to reveal the cardiovascular protective effects of kaempferol-3-<i>O</i>-rutinoside on heart failure.","authors":"Lu-Qin Guo, Lan Zhou, Sheng-Nan Li, Juan Bai, Ling-Li Shi, Fang Hua, Peng Zhou","doi":"10.2478/acph-2025-0001","DOIUrl":"10.2478/acph-2025-0001","url":null,"abstract":"<p><p>Kaempferol-3-<i>O</i>-rutinoside (KR) has an excellent cardioprotective effect, but its mechanism of action is not clear. Network pharmacology was used to predict the signaling pathways, whereas molecular docking was used for preliminary validation of KR binding to targets. AMI model rats with ligated left anterior descending coronary arteries were established. HE staining was used to detect pathological changes, and ELISA was used to detect the expression of TNF-α and IL-6. Network pharmacology results showed PI3K-AKT signaling pathway may be the main mechanism, and molecular docking predicted that KR could bind strongly to the PI3K and AKT. KR could significantly reduce cardiac pathological changes, decrease the level of TNF-α and IL-6, and enhance the mRNA and protein expressions of PI3K and AKT. KR ameliorates HF after AMI by enhancing the expressions of PI3K and AKT, which will be helpful in elucidating the mechanism of KR through multiple techniques.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":" ","pages":"119-132"},"PeriodicalIF":2.1,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142833399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Untargeted metabolic analysis using LC-Q-TOF-MS and toxicity assessment of Eryngium foetidum in zebrafish embryos. LC-Q-TOF-MS法分析斑马鱼胚胎中胎氧的非靶向代谢及毒性评价。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-04-10 Print Date: 2025-03-01 DOI: 10.2478/acph-2025-0008
Romario Vázquez-Cancino, Sergio Rodríguez-Morales, Nelly Del Carmen Jiménez-Pérez, Omar Aristeo Peña-Morán, Litzia Cerón-Romero, Irma Sánchez-Lombardo, Alam Yair-Hidalgo, Nancy Romero Ceronio, Cuauhtémoc Alvarado-Sánchez, Oswaldo Hernández-Abreu

Toxicological studies of edible plant species are important to determine the safety of their consumption. Eryngium foetidum is an edible plant used in some countries for seasoning food and as a natural remedy in folk medicine. Despite this species' gastronomic and medicinal properties, the chemical composition and toxicity have been unclear. The objective of our investigation was to determine the toxic potential of E. foetidum in the zebrafish embryo model and identify the potential compounds involved in its toxicity by electrospray ionization liquid chromatography coupled to quadrupole-time-of-flight mass spectrometry. Acute exposure of zebrafish embryos to n-hexane extract produced higher toxicity than the other extracts in a time- and concentration-dependent fashion (coagulated embryo). A 96-h median lethal concentration (LC 50) of 2.63 µg mL-1 (CI 95 % 0.58-28.5) was calculated by probit analysis. Caudal fin hypertrophy, head, yolk sac edema, caudal region, or somite malformations were observed. Secondary metabolites such as terpenes, polyphenols, and fatty acids were identified in the n-hexane extract. Also, pollutants such as diglycidyl resorcinol ether, diisopropyl adipate, and lauryl sulfate were found in the n-hexane extract. Our study revealed that chemical pollutants could be associated with the embryonic toxicity of the n-hexane extract of E. foetidum.

可食用植物的毒理学研究对确定其食用安全性具有重要意义。羊角草是一种可食用的植物,在一些国家用作调味食品和作为民间医学的天然药物。尽管该物种具有美食和药用特性,但其化学成分和毒性尚不清楚。本研究的目的是通过电喷雾电离液相色谱-四极杆飞行时间质谱联用技术,确定胎儿草在斑马鱼胚胎模型中的潜在毒性,并鉴定其毒性可能涉及的化合物。斑马鱼胚胎急性暴露于正己烷提取物产生的毒性比其他提取物在时间和浓度依赖性(凝固胚胎)。probit分析法计算96 h的中位致死浓度(lc50)为2.63µg mL-1 (CI 95% 0.58 ~ 28.5)。尾鳍肥大、头、卵黄囊水肿、尾鳍区或部分畸形。在正己烷提取物中鉴定出次生代谢物,如萜烯、多酚和脂肪酸。此外,在正己烷提取物中还发现了污染物,如间苯二酚二缩水甘油酯醚、己二酸二异丙酯和硫酸十二烷基。我们的研究表明,化学污染物可能与胎草正己烷提取物的胚胎毒性有关。
{"title":"Untargeted metabolic analysis using LC-Q-TOF-MS and toxicity assessment of <i>Eryngium foetidum</i> in zebrafish embryos.","authors":"Romario Vázquez-Cancino, Sergio Rodríguez-Morales, Nelly Del Carmen Jiménez-Pérez, Omar Aristeo Peña-Morán, Litzia Cerón-Romero, Irma Sánchez-Lombardo, Alam Yair-Hidalgo, Nancy Romero Ceronio, Cuauhtémoc Alvarado-Sánchez, Oswaldo Hernández-Abreu","doi":"10.2478/acph-2025-0008","DOIUrl":"https://doi.org/10.2478/acph-2025-0008","url":null,"abstract":"<p><p>Toxicological studies of edible plant species are important to determine the safety of their consumption. <i>Eryngium foetidum</i> is an edible plant used in some countries for seasoning food and as a natural remedy in folk medicine. Despite this species' gastronomic and medicinal properties, the chemical composition and toxicity have been unclear. The objective of our investigation was to determine the toxic potential of <i>E. foetidum</i> in the zebrafish embryo model and identify the potential compounds involved in its toxicity by electrospray ionization liquid chromatography coupled to quadrupole-time-of-flight mass spectrometry. Acute exposure of zebrafish embryos to <i>n</i>-hexane extract produced higher toxicity than the other extracts in a time- and concentration-dependent fashion (coagulated embryo). A 96-h median lethal concentration (<i>LC</i> <sub>50</sub>) of 2.63 µg mL<sup>-1</sup> (CI 95 % 0.58-28.5) was calculated by probit analysis. Caudal fin hypertrophy, head, yolk sac edema, caudal region, or somite malformations were observed. Secondary metabolites such as terpenes, polyphenols, and fatty acids were identified in the <i>n</i>-hexane extract. Also, pollutants such as diglycidyl resorcinol ether, diisopropyl adipate, and lauryl sulfate were found in the <i>n</i>-hexane extract. Our study revealed that chemical pollutants could be associated with the embryonic toxicity of the <i>n</i>-hexane extract of <i>E. foetidum</i>.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":"75 1","pages":"133-146"},"PeriodicalIF":2.1,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143958002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic effect of umbilical cord mesenchymal stem cells on renal ischemia-reperfusion injury. 脐带间充质干细胞对肾缺血再灌注损伤的治疗作用。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-04-10 Print Date: 2025-03-01 DOI: 10.2478/acph-2025-0006
Liang Xiao, Chengyu Huang, Shanghua Xiao, Lingfeng Xie, Xueyan Zhang, Fucheng Xiao, Huajia Cai, Shuibo Yang, Shengqing Wu, Shoukang Qu, Jia Liu

Acute kidney injury (AKI) is a growing global health issue with no effective treatments. This study evaluates the therapeutic effects of umbilical cord mesenchymal stem cells (UC-MSCs) on AKI caused by ischemia-reperfusion injury (IRI) in mice. Thirty mice were divided into a sham group, an IRI group, and an MSC-treated group. Renal function was assessed, and histological analysis, immunofluorescence, and real-time PCR were used to evaluate renal damage, inflammatory cell presence, and cytokine expression (TNF-α, IL-6, IL-10). Results showed that MSC treatment reduced renal damage, decreased pro-inflammatory cytokines (TNF-α, IL-6), increased anti-inflammatory IL-10, and promoted kidney repair by homing to injury sites. Thus, umbilical cord MSCs may mitigate AKI by reducing inflammation and enhancing renal repair.

急性肾损伤(AKI)是一个日益严重的全球性健康问题,目前尚无有效的治疗方法。本研究评价脐带间充质干细胞(UC-MSCs)对小鼠缺血再灌注损伤(IRI)所致AKI的治疗作用。将30只小鼠分为假手术组、IRI组和msc治疗组。评估肾功能,采用组织学分析、免疫荧光和实时荧光定量PCR评估肾脏损害、炎症细胞存在和细胞因子表达(TNF-α、IL-6、IL-10)。结果显示,MSC治疗可减轻肾损伤,降低促炎细胞因子(TNF-α, IL-6),增加抗炎IL-10,并通过损伤部位的归巢促进肾脏修复。因此,脐带间充质干细胞可能通过减少炎症和增强肾脏修复来减轻AKI。
{"title":"Therapeutic effect of umbilical cord mesenchymal stem cells on renal ischemia-reperfusion injury.","authors":"Liang Xiao, Chengyu Huang, Shanghua Xiao, Lingfeng Xie, Xueyan Zhang, Fucheng Xiao, Huajia Cai, Shuibo Yang, Shengqing Wu, Shoukang Qu, Jia Liu","doi":"10.2478/acph-2025-0006","DOIUrl":"https://doi.org/10.2478/acph-2025-0006","url":null,"abstract":"<p><p>Acute kidney injury (AKI) is a growing global health issue with no effective treatments. This study evaluates the therapeutic effects of umbilical cord mesenchymal stem cells (UC-MSCs) on AKI caused by ischemia-reperfusion injury (IRI) in mice. Thirty mice were divided into a sham group, an IRI group, and an MSC-treated group. Renal function was assessed, and histological analysis, immunofluorescence, and real-time PCR were used to evaluate renal damage, inflammatory cell presence, and cytokine expression (TNF-α, IL-6, IL-10). Results showed that MSC treatment reduced renal damage, decreased pro-inflammatory cytokines (TNF-α, IL-6), increased anti-inflammatory IL-10, and promoted kidney repair by homing to injury sites. Thus, umbilical cord MSCs may mitigate AKI by reducing inflammation and enhancing renal repair.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":"75 1","pages":"103-118"},"PeriodicalIF":2.1,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143959464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling the antiglioblastoma potential of harmicens, harmine and ferrocene hybrids. 揭示蒿甲素、蒿乙素和二茂铁混合物的抗胶质母细胞瘤潜力。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0033
Goran Poje, Davor Šakić, Marina Marinović, Jiangyang You, Michael Tarpley, Kevin P Williams, Nikolina Golub, Jaka Dernovšek, Tihomir Tomašič, Erim Bešić, Zrinka Rajić

The poor prognosis of glioblastoma multiforme, inadequate treatment options, and growing drug resistance urge the need to find new effective agents. Due to the significant anti-cancer potential of harmicens, hybrid compounds which comprise harmine/β-carboline and ferrocene moiety, we investigated their antiglioblastoma potential in vitro and mechanism of action (inhibition of DYRK1A, Hsp90, anti-oxidative activity). The results have shown that triazole-type harmicens, namely 5, with a ferrocene moiety in C-3 position of the β-carboline ring (IC 50 = 3.7 ± 0.1 µmol L-1, SI = 12.6) and ., the C-6 substituted harmicene (IC 50 = 7.4 ± 0.5 µmol L-1, SI = 5.8) exert remarkable activity and selectivity against human malignant glioblastoma cell line (U251) in vitro. On the other hand, amide-type harmicens 10, 12, and 14 exhibited strong, but non-selective activity, in the low micro-molar range. Mechanistic studies revealed that among active compounds, amide-type harmicens 12 and 14 inhibit DYRK1A and Hsp90 CTD, whereas compound 14 showed pronounced antioxidative activity. Therefore, the antiproliferative activity of harmicens might be a combination of complex molecular interactions.

多形性胶质母细胞瘤预后不佳,治疗方案不足,耐药性不断增加,因此需要寻找新的有效药物。鉴于蒿甲素(由蒿甲素/β-咔啉和二茂铁组成的杂化化合物)的抗癌潜力巨大,我们对其体外抗胶质母细胞瘤的潜力和作用机制(抑制 DYRK1A、Hsp90、抗氧化活性)进行了研究。结果表明,三唑类胭脂虫,即在β-咔啉环的 C-3 位具有二茂铁分子的 5(IC 50 = 3.7 ± 0.1 µmol L-1,SI = 12.6)和 C-6 取代的胭脂虫 9(IC 50 = 7.4 ± 0.5 µmol L-1,SI = 5.8),在体外对人类恶性胶质母细胞瘤细胞株(U251)具有显著的活性和选择性。另一方面,酰胺型伤害素 10、12 和 14 在低微摩尔范围内表现出很强的活性,但无选择性。机理研究表明,在活性化合物中,酰胺型蒿甲素 12 和 14 可抑制 DYRK1A 和 Hsp90 CTD,而化合物 14 则具有明显的抗氧化活性。因此,蒿甲素的抗增殖活性可能是复杂的分子相互作用的综合结果。
{"title":"Unveiling the antiglioblastoma potential of harmicens, harmine and ferrocene hybrids.","authors":"Goran Poje, Davor Šakić, Marina Marinović, Jiangyang You, Michael Tarpley, Kevin P Williams, Nikolina Golub, Jaka Dernovšek, Tihomir Tomašič, Erim Bešić, Zrinka Rajić","doi":"10.2478/acph-2024-0033","DOIUrl":"10.2478/acph-2024-0033","url":null,"abstract":"<p><p>The poor prognosis of glioblastoma multiforme, inadequate treatment options, and growing drug resistance urge the need to find new effective agents. Due to the significant anti-cancer potential of harmicens, hybrid compounds which comprise harmine/β-carboline and ferrocene moiety, we investigated their antiglioblastoma potential <i>in vitro</i> and mechanism of action (inhibition of DYRK1A, Hsp90, anti-oxidative activity). The results have shown that triazole-type harmicens, namely <b>5</b>, with a ferrocene moiety in C-3 position of the β-carboline ring (<i>IC</i> <sub>50</sub> = 3.7 ± 0.1 µmol L-1, SI = 12.6) and ., the C-6 substituted harmicene (<i>IC</i> <sub>50</sub> = 7.4 ± 0.5 µmol L-1, SI = 5.8) exert remarkable activity and selectivity against human malignant glioblastoma cell line (U251) <i>in vitro</i>. On the other hand, amide-type harmicens <b>10</b>, <b>12</b>, and <b>14</b> exhibited strong, but non-selective activity, in the low micro-molar range. Mechanistic studies revealed that among active compounds, amide-type harmicens <b>12</b> and <b>14</b> inhibit DYRK1A and Hsp90 CTD, whereas compound <b>14</b> showed pronounced antioxidative activity. Therefore, the antiproliferative activity of harmicens might be a combination of complex molecular interactions.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":" ","pages":"595-612"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phenolic content and antioxidant activity of Croatian and German honey. 克罗地亚和德国蜂蜜的酚含量和抗氧化活性。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0031
Valerija Vujčić Bok, Ivana Šola, Gordana Rusak, Alan Budisavljević, Rosa Nguyen, Jutta Ludwig-Müller, Željan Maleš

Since honey has a therapeutic role in the treatment of many diseases, we investigated the content of phenolic compounds and the antioxidant activity in acacia (Robinia pseudoacacia L.), chestnut (Castanea sativa Mill.) and lime-tree (Tilia spp.) honey originating from Croatia and Germany. Total phenols, flavonols, and flavanols contents were observed at higher levels in Croatian Castanea honey compared to German Castanea honey. Significant higher values of total flavanols and hydroxycinnamic acids were measured in Croatian Tilia honey compared to German Tilia honey. For Robinia honey, significantly higher values of total phenols and flavonols were observed in almost all Croatian honey samples compared to German honey. Croatian honey samples had higher antioxidant activity compared to German honey samples with most tested methods. The highest total phenols, total flavanols, ABTS, DPPH, and FRAP values were measured in Castanea honey, then in Robinia honey, and the lowest values in Tilia honey samples. With new developed HPLC method, pinobanksin, pinocembrin, and chrysin were identified in the majority of honey samples. Our results imply that both botanical and geographical origin influence the final quality of phenolic compounds and antioxidant activity in honey. A high positive correlation between the results of antioxidant activity and polyphenols was detected.

由于蜂蜜在治疗多种疾病方面具有治疗作用,我们研究了产自克罗地亚和德国的刺槐(Robinia pseudoacacia L.)、栗树(Castanea sativa Mill.)和椴树(Tilia spp.)蜂蜜中的酚类化合物含量和抗氧化活性。与德国蓖麻蜂蜜相比,克罗地亚蓖麻蜂蜜的总酚、黄酮醇和黄烷醇含量较高。克罗地亚椴树蜂蜜的总黄烷醇和羟基肉桂酸含量明显高于德国椴树蜂蜜。就洋槐蜂蜜而言,与德国蜂蜜相比,几乎所有克罗地亚蜂蜜样品的总酚和黄酮醇值都明显较高。在大多数测试方法中,克罗地亚蜂蜜样品的抗氧化活性高于德国蜂蜜样品。蓖麻蜂蜜的总酚、总黄烷醇、ABTS、DPPH 和 FRAP 值最高,然后是洋槐蜂蜜,而椴树蜂蜜的值最低。采用新开发的高效液相色谱法,在大多数蜂蜜样品中都鉴定出了松柏黄酮素、松柏黄酮素和菊花黄酮素。我们的研究结果表明,植物和地理产地都会影响蜂蜜中酚类化合物的最终质量和抗氧化活性。抗氧化活性与多酚类化合物之间存在高度正相关。
{"title":"Phenolic content and antioxidant activity of Croatian and German honey.","authors":"Valerija Vujčić Bok, Ivana Šola, Gordana Rusak, Alan Budisavljević, Rosa Nguyen, Jutta Ludwig-Müller, Željan Maleš","doi":"10.2478/acph-2024-0031","DOIUrl":"10.2478/acph-2024-0031","url":null,"abstract":"<p><p>Since honey has a therapeutic role in the treatment of many diseases, we investigated the content of phenolic compounds and the antioxidant activity in acacia (<i>Robinia pseudoacacia</i> L.), chestnut (<i>Castanea sativa</i> Mill.) and lime-tree (<i>Tilia</i> spp.) honey originating from Croatia and Germany. Total phenols, flavonols, and flavanols contents were observed at higher levels in Croatian <i>Castanea</i> honey compared to German <i>Castanea</i> honey. Significant higher values of total flavanols and hydroxycinnamic acids were measured in Croatian <i>Tilia</i> honey compared to German <i>Tilia</i> honey. For <i>Robinia</i> honey, significantly higher values of total phenols and flavonols were observed in almost all Croatian honey samples compared to German honey. Croatian honey samples had higher antioxidant activity compared to German honey samples with most tested methods. The highest total phenols, total flavanols, ABTS, DPPH, and FRAP values were measured in <i>Castanea</i> honey, then in <i>Robinia</i> honey, and the lowest values in <i>Tilia</i> honey samples. With new developed HPLC method, pinobanksin, pinocembrin, and chrysin were identified in the majority of honey samples. Our results imply that both botanical and geographical origin influence the final quality of phenolic compounds and antioxidant activity in honey. A high positive correlation between the results of antioxidant activity and polyphenols was detected.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":" ","pages":"673-692"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Light-induced rearrangement from macrocyclic to bicyclic lactam: A case study of N-chlorinated laurolactam. 从大环内酰胺到双环内酰胺的光诱导重排:N-chlorinated laurolactam 的案例研究。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0035
Gabrijel Zubčić, Kristina Pavić, Jiangyang You, Valerije Vrček, Tomislav Portada, Erim Bešić, Davor Šakić

Converting macrocycle lactams into bicyclic lactams is proposed as an additional way to further increase the metabolic stability of peptide-based drugs. Unfortunately, the synthesis of bicyclic lactams has to start almost from scratch. This study explores the Hofmann-Löffler-Freytag (HLF) reaction mechanism and products as a potential late-stage functionalisation strategy for facile conversion of macrocyclic to bicyclic ring. Laurolactam, a macrocyclic amide, exhibits significant potential for transformation into bioactive bicyclic structures with smaller, β-, γ-, δ-, and ε-lactam rings, further increasing rigidity and hydrolytic stability. With irradiation provided by a 370 nm lamp, light-induced rearrangement reaction was monitored using nuclear magnetic resonance (NMR), while involved radical intermediates were trapped using N-tert-butyl-α-phenylnitrone (PBN) spin-trap and characterised via EPR. While only two radical adduct types were identified in the electron para magnetic resonance (EPR) (C-centered radical and chlorine radical), all eight possible products are observed in the NMR. Quantum chemical calculations provide deeper insights into reaction thermodynamics and kinetics, explaining why the N-centered radical was not observed. This research highlights the feasibility of using the HLF reaction to transform macrocyclic lactams into stable bicyclic drug candidates, paving the way for new therapeutic developments.

将大环内酰胺转化为双环内酰胺是进一步提高肽类药物代谢稳定性的另一种方法。遗憾的是,双环内酰胺的合成几乎要从零开始。本研究探讨了霍夫曼-洛夫勒-弗雷塔格(HLF)反应机理和产物,以此作为一种潜在的后期官能化策略,实现大环到双环的便捷转化。月桂内酰胺是一种大环酰胺,具有转化为具有较小的β-、γ-、δ-和ε-内酰胺环的生物活性双环结构的巨大潜力,可进一步提高刚性和水解稳定性。在 370 nm 灯的照射下,利用核磁共振 (NMR) 对光诱导的重排反应进行监测,同时利用 N-叔丁基-α-苯基硝酮 (PBN) 自旋阱捕获所涉及的自由基中间体,并通过 EPR 对其进行表征。虽然在电子对位磁共振(EPR)中只确定了两种自由基加合物类型(C-中心自由基和氯自由基),但在核磁共振中观察到了所有八种可能的产物。量子化学计算深入揭示了反应热力学和动力学,解释了为什么没有观察到以 N 为中心的自由基。这项研究强调了利用 HLF 反应将大环内酰胺转化为稳定的双环候选药物的可行性,为新疗法的开发铺平了道路。
{"title":"Light-induced rearrangement from macrocyclic to bicyclic lactam: A case study of <i>N</i>-chlorinated laurolactam.","authors":"Gabrijel Zubčić, Kristina Pavić, Jiangyang You, Valerije Vrček, Tomislav Portada, Erim Bešić, Davor Šakić","doi":"10.2478/acph-2024-0035","DOIUrl":"10.2478/acph-2024-0035","url":null,"abstract":"<p><p>Converting macrocycle lactams into bicyclic lactams is proposed as an additional way to further increase the metabolic stability of peptide-based drugs. Unfortunately, the synthesis of bicyclic lactams has to start almost from scratch. This study explores the Hofmann-Löffler-Freytag (HLF) reaction mechanism and products as a potential late-stage functionalisation strategy for facile conversion of macrocyclic to bicyclic ring. Laurolactam, a macrocyclic amide, exhibits significant potential for transformation into bioactive bicyclic structures with smaller, β-, γ-, δ-, and ε-lactam rings, further increasing rigidity and hydrolytic stability. With irradiation provided by a 370 nm lamp, light-induced rearrangement reaction was monitored using nuclear magnetic resonance (NMR), while involved radical intermediates were trapped using <i>N</i>-<i>tert</i>-butyl-α-phenylnitrone (PBN) spin-trap and characterised <i>via</i> EPR. While only two radical adduct types were identified in the electron para magnetic resonance (EPR) (<i>C</i>-centered radical and chlorine radical), all eight possible products are observed in the NMR. Quantum chemical calculations provide deeper insights into reaction thermodynamics and kinetics, explaining why the <i>N</i>-centered radical was not observed. This research highlights the feasibility of using the HLF reaction to transform macrocyclic lactams into stable bicyclic drug candidates, paving the way for new therapeutic developments.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":" ","pages":"725-737"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and factors associated with potential clinically significant drug-drug interactions in patients with cardiovascular diseases at hospital admission. 住院时心血管疾病患者中潜在临床显著药物-药物相互作用的患病率及相关因素
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0038
Iva Marović, Mario Udovičić, Diana Rudan, Šime Manola, Ivana Samardžić, Vesna Bačić Vrca, Maja Ortner Hadžiabdić, Ivana Marinović
<p><p>Cardiovascular diseases (CVDs) are the leading cause of mortality and morbidity globally. It is estimated that 17.9 million people died from CVDs in 2019, which represents 32 % of all deaths worldwide. Cardiovascular drugs are the most common medical intervention for the prevention of cardiovascular events. CV medications have many benefits however their application is often complicated by multimorbidity and polypharmacy. Drug-drug interactions (DDIs) can lead to adverse drug events, hospitalizations, prolonged hospital stays, increased healthcare costs, and increased risk of mortality. Hospital admission provides an opportunity for pharmacotherapy analysis and for identifying DDIs which can jeopardize medication safety. The aim of this study is to determine the type and prevalence of potential clinically significant DDIs in patients with CVD and to examine factors associated with exposure to DDIs. A prospective study was conducted at the Dubrava University Hospital at the Clinic of Cardiology during a 6-month period (September 2023 - February 2024). Demographic, clinical and pharmacotherapy data were collected for each patient. The first prescribed pharmacotherapy was analyzed. The research was approved by the Hospital's Ethics Committee and each patient involved in the study signed an informed consent. Lexicomp<sup>®</sup> Lexi-InteractTM Online (Lexi-Comp, Inc., USA) was used for DDI analysis. Poisson regression was used for regression analysis for determining risk factors associated with exposure to DDIs. Total of 151 patients admitted to Cardiology ward were included in the research, and the average age was 67 years. Patients had an average of 9 medications in their therapy and 8 diagnoses. Overall, 1268 potential clinically significant DDIs were determined, of which the most frequently determined interactions were grade C (90.9 %), then grade D (8.6 %) and grade X (0.6 %). CV medications were involved in 88 % DDIs. The most common interventions regarding identified DDIs included exclusion one of the drugs, dose adjustment, increased monitoring of signs of bleeding, cardiac disorders, hypoglycemia, CNS depression and rhabdomyolysis, blood pressure, markers of renal function and electrolyte status. Factors associated with the prevalence of potential clinically significant DDIs were decreased renal function, recent hospitalization, total number of comorbidities and polypharmacy. Specific comorbidities associated with DDIs were arrhythmia, heart failure, diabetes mellitus and disease of the respiratory system. A high prevalence of DDIs of CV medications in all categories of clinical significance was determined. Managing medication safety in specific patient groups with CVDs can represent a greater challenge regarding DDIs. Certain medical conditions, such as arrhythmia, heart failure, diabetes, and diseases of the respiratory system, multimorbidity, polypharmacy, impaired renal function and recent hospitalization are identified in this re
心血管疾病(cvd)是全球死亡和发病的主要原因。据估计,2019年有1790万人死于心血管疾病,占全球死亡人数的32%。心血管药物是预防心血管事件最常用的医疗干预手段。心血管药物有很多好处,但他们的应用往往是复杂的多病和多药。药物-药物相互作用(ddi)可导致药物不良事件、住院、延长住院时间、增加医疗保健费用和增加死亡风险。住院为药物治疗分析和确定可能危及用药安全的ddi提供了机会。本研究的目的是确定CVD患者中潜在临床意义的ddi的类型和患病率,并检查与ddi暴露相关的因素。在杜布拉瓦大学医院心脏病诊所进行了为期6个月的前瞻性研究(2023年9月至2024年2月)。收集每位患者的人口学、临床和药物治疗数据。对第一次处方药物治疗进行分析。该研究得到了医院伦理委员会的批准,参与研究的每位患者都签署了知情同意书。使用Lexicomp®Lexi-InteractTM Online (Lexi-Comp, Inc., USA)进行DDI分析。泊松回归用于回归分析,以确定与ddi暴露相关的危险因素。本研究共纳入151例心脏病病房住院患者,平均年龄为67岁。患者在治疗中平均有9种药物和8种诊断。总的来说,1268个潜在的临床显著性ddi被确定,其中最常见的相互作用是C级(90.9%),然后是D级(8.6%)和X级(0.6%)。88%的ddi涉及心血管药物。对于已确定的ddi,最常见的干预措施包括排除一种药物、调整剂量、增加对出血、心脏疾病、低血糖、中枢神经系统抑制和横纹肌溶解症状的监测、血压、肾功能指标和电解质状态。与潜在临床意义的ddi患病率相关的因素有肾功能下降、近期住院、合并症总数和多种用药。与ddi相关的具体合并症有心律失常、心力衰竭、糖尿病和呼吸系统疾病。在所有临床意义的类别中,CV药物ddi的高流行率被确定。管理特定心血管疾病患者群体的用药安全对于ddi来说是一个更大的挑战。某些医疗条件,如心律失常、心力衰竭、糖尿病和呼吸系统疾病、多病、多药、肾功能受损和近期住院,在本研究中被确定为与心血管疾病患者住院时发生ddi相关的附加因素。住院是管理用药安全的关键环节之一。临床药师应定期对处方药物治疗中的ddi进行分析,提高用药安全性,提高医疗服务质量。
{"title":"Prevalence and factors associated with potential clinically significant drug-drug interactions in patients with cardiovascular diseases at hospital admission.","authors":"Iva Marović, Mario Udovičić, Diana Rudan, Šime Manola, Ivana Samardžić, Vesna Bačić Vrca, Maja Ortner Hadžiabdić, Ivana Marinović","doi":"10.2478/acph-2024-0038","DOIUrl":"10.2478/acph-2024-0038","url":null,"abstract":"&lt;p&gt;&lt;p&gt;Cardiovascular diseases (CVDs) are the leading cause of mortality and morbidity globally. It is estimated that 17.9 million people died from CVDs in 2019, which represents 32 % of all deaths worldwide. Cardiovascular drugs are the most common medical intervention for the prevention of cardiovascular events. CV medications have many benefits however their application is often complicated by multimorbidity and polypharmacy. Drug-drug interactions (DDIs) can lead to adverse drug events, hospitalizations, prolonged hospital stays, increased healthcare costs, and increased risk of mortality. Hospital admission provides an opportunity for pharmacotherapy analysis and for identifying DDIs which can jeopardize medication safety. The aim of this study is to determine the type and prevalence of potential clinically significant DDIs in patients with CVD and to examine factors associated with exposure to DDIs. A prospective study was conducted at the Dubrava University Hospital at the Clinic of Cardiology during a 6-month period (September 2023 - February 2024). Demographic, clinical and pharmacotherapy data were collected for each patient. The first prescribed pharmacotherapy was analyzed. The research was approved by the Hospital's Ethics Committee and each patient involved in the study signed an informed consent. Lexicomp&lt;sup&gt;®&lt;/sup&gt; Lexi-InteractTM Online (Lexi-Comp, Inc., USA) was used for DDI analysis. Poisson regression was used for regression analysis for determining risk factors associated with exposure to DDIs. Total of 151 patients admitted to Cardiology ward were included in the research, and the average age was 67 years. Patients had an average of 9 medications in their therapy and 8 diagnoses. Overall, 1268 potential clinically significant DDIs were determined, of which the most frequently determined interactions were grade C (90.9 %), then grade D (8.6 %) and grade X (0.6 %). CV medications were involved in 88 % DDIs. The most common interventions regarding identified DDIs included exclusion one of the drugs, dose adjustment, increased monitoring of signs of bleeding, cardiac disorders, hypoglycemia, CNS depression and rhabdomyolysis, blood pressure, markers of renal function and electrolyte status. Factors associated with the prevalence of potential clinically significant DDIs were decreased renal function, recent hospitalization, total number of comorbidities and polypharmacy. Specific comorbidities associated with DDIs were arrhythmia, heart failure, diabetes mellitus and disease of the respiratory system. A high prevalence of DDIs of CV medications in all categories of clinical significance was determined. Managing medication safety in specific patient groups with CVDs can represent a greater challenge regarding DDIs. Certain medical conditions, such as arrhythmia, heart failure, diabetes, and diseases of the respiratory system, multimorbidity, polypharmacy, impaired renal function and recent hospitalization are identified in this re","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":"74 4","pages":"693-708"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142942402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimization of the suspension procedure by Box-Behnken design for the determination of manganese, iron, and zinc in zeolite clinoptilolite with the TXRF system and insight into its antioxidant properties. 采用Box-Behnken设计优化悬浮流程,利用TXRF系统测定沸石斜沸石中的锰、铁和锌,并深入了解其抗氧化性能。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0040
Jasna Jablan, Maja Bival Štefan, Dario Paler, Emma Kamenski

Zeolites are a large family of minerals and the most studied is the naturally occurring clinoptilolite. They possess anti-inflammatory, antioxidant, and detoxifying properties which makes them valuable for medicinal use. Element analysis of zeolite's composition is necessary for its precise chemical characterization, and within this work development of a suspension method for the determination of manga nese, iron, and zinc by total reflection X-ray fluorescence spec-trometry (TXRF) was presented. The Box-Behnken design based on the response surface methodology was applied to determine the optimal sample preparation conditions. The significant variables such as sample amount, volume deposition, and dispersant were selected as critical variables. Based on the results obtained, sample suspensions were prepared by weighing 10 mg of the sample and adding 1 mL of 5 % Triton X-100 with 10 mL Ga as internal standard and deposition volume was set at 10 mL. The results obtained with TXRF were comparable with those obtained with the FAAS method, indicating that this technique can be used instead of the conventional methods. Using the best analytical conditions, the limits of detection for trace elements were in the range of 0.2-0.6 mg kg-1. Trueness and precision of the results, evaluated by CRM sample analysis, were in most cases acceptable with recoveries values in the range of 104.9-111.4 % and relative standard deviations of 2-10 % (. = 6). Zeolites showed no ability to quench free radicals nor the ability to influence dietary antioxidants.

沸石是一大类矿物,研究最多的是自然产生的斜沸石。它们具有抗炎、抗氧化和排毒的特性,这使它们具有药用价值。对沸石的组成进行元素分析是其精确化学表征的必要条件,本文提出了用全反射x射线荧光光谱法(TXRF)悬浮法测定锰、铁和锌的方法。采用基于响应面法的Box-Behnken设计确定最佳制样条件。选取样品数量、体积沉积和分散剂等重要变量作为关键变量。在此基础上,取10 mg样品称重,加入1 mL 5% Triton X-100,以10 mL Ga为内标,沉积体积为10 mL,制备样品悬浮液。TXRF法与火焰原子吸收光谱法所得结果相当,表明该技术可替代传统方法。在最佳分析条件下,样品中微量元素的检出限为0.2 ~ 0.6 mg kg-1。结果的准确性和精密度,通过CRM样品分析评估,在大多数情况下,回收率在104.9- 114%范围内,相对标准偏差为2- 10%()。= 6)。沸石对自由基没有抑制作用,对膳食抗氧化剂也没有影响。
{"title":"Optimization of the suspension procedure by Box-Behnken design for the determination of manganese, iron, and zinc in zeolite clinoptilolite with the TXRF system and insight into its antioxidant properties.","authors":"Jasna Jablan, Maja Bival Štefan, Dario Paler, Emma Kamenski","doi":"10.2478/acph-2024-0040","DOIUrl":"10.2478/acph-2024-0040","url":null,"abstract":"<p><p>Zeolites are a large family of minerals and the most studied is the naturally occurring clinoptilolite. They possess anti-inflammatory, antioxidant, and detoxifying properties which makes them valuable for medicinal use. Element analysis of zeolite's composition is necessary for its precise chemical characterization, and within this work development of a suspension method for the determination of manga nese, iron, and zinc by total reflection X-ray fluorescence spec-trometry (TXRF) was presented. The Box-Behnken design based on the response surface methodology was applied to determine the optimal sample preparation conditions. The significant variables such as sample amount, volume deposition, and dispersant were selected as critical variables. Based on the results obtained, sample suspensions were prepared by weighing 10 mg of the sample and adding 1 mL of 5 % Triton X-100 with 10 mL Ga as internal standard and deposition volume was set at 10 mL. The results obtained with TXRF were comparable with those obtained with the FAAS method, indicating that this technique can be used instead of the conventional methods. Using the best analytical conditions, the limits of detection for trace elements were in the range of 0.2-0.6 mg kg<sup>-1</sup>. Trueness and precision of the results, evaluated by CRM sample analysis, were in most cases acceptable with recoveries values in the range of 104.9-111.4 % and relative standard deviations of 2-10 % (. = 6). Zeolites showed no ability to quench free radicals nor the ability to influence dietary antioxidants.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":"74 4","pages":"655-672"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142942401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fall risk-increasing drugs and associated health outcomes among community-dwelling older patients: A cross-sectional study in Croatian cohort of the EuroAgeism H2020 project. 在社区居住的老年患者中,增加跌倒风险的药物和相关健康结果:欧洲老龄化 H2020 项目克罗地亚队列横断面研究。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0034
Elizabeta Paar, Eleonora De Lai, Margita Držaić, Ingrid Kummer, Iva Bužančić, Maja Ortner Hadžiabdić, Jovana Brkic, Daniela Fialová

Our study aimed to assess the prevalence of fall risk-increasing drugs (FRIDs) in a sample of community-residing older patients in Croatia and its association with negative health outcomes. An observational, cross-sectional study was conducted on older patients (65+) visiting community pharmacies in three regionally different study sites in Croatia. Data were collected using a questionnaire developed for that purpose and included components of comprehensive geriatric assessment. Prevalence of FRIDs was identified using the "Screening Tool of Older Persons Prescriptions in older adults with high fall risk" (STOPPFall). In the sample of 407 participants (median age 73 (IQR 69-70) years; 63.9 % females), 79.1 % used at least one FRID. The most common drug classes were diuretics, benzodiazepines, and opioids (in 51.1 %, 38.1 %, and 17.2 % participants, respectively). More FRIDs were prescribed to the oldest old patients (85+) and participants from poorer regions of Croatia (Slavonia) (p < 0.05). Exposition to FRIDs was identified as the significant risk factor associated with falls (OR = 1.24 (1.04-1.50); p = 0.020) and higher health-care utilization (OR = 1.29 (1.10-1.51); p = 0.001). Our study highlights the need for rationalization of FRID use. To reduce the unnecessary exposure to FRIDs in older adults, health-care professionals must consider high individualization of medication schemes regarding selection, dosing, and combinations of only necessary FRIDs.

我们的研究旨在评估在克罗地亚社区居住的老年患者样本中增加跌倒风险药物(FRIDs)的使用率及其与不良健康后果之间的关系。我们对克罗地亚三个不同地区的社区药房就诊的老年患者(65 岁以上)进行了横断面观察研究。数据的收集使用了一份为此目的开发的调查问卷,其中包括老年病综合评估的内容。使用 "高跌倒风险老年人处方筛查工具"(STOPPFall)确定了 FRID 的患病率。在 407 名参与者(中位数年龄为 73(IQR 69-70)岁;63.9% 为女性)中,79.1% 至少使用过一种 FRID。最常见的药物类别是利尿剂、苯二氮卓类药物和阿片类药物(分别占 51.1%、38.1% 和 17.2%)。最年长的老年患者(85 岁以上)和来自克罗地亚较贫困地区(斯拉沃尼亚)的参与者处方的 FRIDs 较多(P < 0.05)。接触 FRIDs 被认为是与跌倒(OR = 1.24 (1.04-1.50); p = 0.020)和更高的医疗保健使用率(OR = 1.29 (1.10-1.51); p = 0.001)相关的重要风险因素。我们的研究强调了合理使用 FRID 的必要性。为了减少老年人不必要地接触 FRIDs,医护人员必须考虑在选择、剂量和仅必要的 FRIDs 组合方面高度个性化的用药方案。
{"title":"Fall risk-increasing drugs and associated health outcomes among community-dwelling older patients: A cross-sectional study in Croatian cohort of the EuroAgeism H2020 project.","authors":"Elizabeta Paar, Eleonora De Lai, Margita Držaić, Ingrid Kummer, Iva Bužančić, Maja Ortner Hadžiabdić, Jovana Brkic, Daniela Fialová","doi":"10.2478/acph-2024-0034","DOIUrl":"10.2478/acph-2024-0034","url":null,"abstract":"<p><p>Our study aimed to assess the prevalence of fall risk-increasing drugs (FRIDs) in a sample of community-residing older patients in Croatia and its association with negative health outcomes. An observational, cross-sectional study was conducted on older patients (65+) visiting community pharmacies in three regionally different study sites in Croatia. Data were collected using a questionnaire developed for that purpose and included components of comprehensive geriatric assessment. Prevalence of FRIDs was identified using the \"Screening Tool of Older Persons Prescriptions in older adults with high fall risk\" (STOPPFall). In the sample of 407 participants (median age 73 (IQR 69-70) years; 63.9 % females), 79.1 % used at least one FRID. The most common drug classes were diuretics, benzodiazepines, and opioids (in 51.1 %, 38.1 %, and 17.2 % participants, respectively). More FRIDs were prescribed to the oldest old patients (85+) and participants from poorer regions of Croatia (Slavonia) (<i>p</i> < 0.05). Exposition to FRIDs was identified as the significant risk factor associated with falls (OR = 1.24 (1.04-1.50); <i>p</i> = 0.020) and higher health-care utilization (OR = 1.29 (1.10-1.51); <i>p</i> = 0.001). Our study highlights the need for rationalization of FRID use. To reduce the unnecessary exposure to FRIDs in older adults, health-care professionals must consider high individualization of medication schemes regarding selection, dosing, and combinations of only necessary FRIDs.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":" ","pages":"635-653"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Pharmaceutica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1